In food protection, further providing for misbranding of food.
Summary
HB1133 would amend Pennsylvania’s food misbranding law to require a specific cancer warning on any food that bears or contains butylated hydroxyanisole (BHA), identified by its CAS number 25013-16-5. Under the bill, such a product would be considered misbranded unless it displays, in boldface type on the principal display panel, the warning: “WARNING: This product contains BHA, which may cause cancer.” The warning would have to be at least as large as the federally required serving-size declaration.
The bill also adds a definition of “CAS” to mean the Chemical Abstracts Service accession number assigned to a substance. If enacted, the measure would take effect one year after passage, giving manufacturers and retailers time to adjust labels and packaging. The bill operates within Title 3 of Pennsylvania’s consolidated statutes, specifically the state’s food protection and misbranding provisions, and would create a new labeling condition for foods containing BHA.
Impact
HB1133 would expand Pennsylvania’s misbranding standards by making BHA-containing foods unlawful to sell as labeled unless they carry the specified cancer warning. This would affect food manufacturers, distributors, and retailers that use BHA as a preservative or antioxidant, likely requiring label redesign, compliance review, and possible reformulation or product withdrawal for items sold in Pennsylvania. The bill would not ban BHA outright, but it would impose a state-specific warning requirement that could interact with federal food labeling rules and create enforcement obligations under the state’s food safety framework.
Sentiment
There is no recorded committee transcript or vote history in the provided materials, so no formal legislative debate or recorded sentiment is available. Based on the bill text alone, the measure appears to reflect a precautionary public-health approach focused on consumer warning and cancer risk disclosure. The broad bipartisan-looking sponsor list suggests at least some cross-party interest, but the absence of discussion or votes means support and opposition cannot be reliably measured from the available record.
Contention
The main point of contention is likely to be whether BHA actually warrants a cancer warning on food labels and whether Pennsylvania should impose a state-specific requirement beyond federal labeling standards. Supporters would likely emphasize consumer right-to-know and precautionary labeling, while opponents may argue the warning is scientifically disputed, could confuse consumers, and would impose compliance costs on food companies. Another likely issue is preemption or consistency with federal food labeling law, since the bill creates a mandatory warning tied to a specific additive.